Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 2933
Selected: 0
NCT IDTitle
NCT01730534Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events
NCT04969887Combination Immunotherapy in Rare Cancers Under InvesTigation
NCT01129063Pharmacokinetic Study of Single Doses of Clopidogrel, 75 mg and 300 mg, in Healthy Subjects
NCT01629758Safety Study of IL-21/Anti-PD-1 Combination in the Treatment of Solid Tumors
NCT02651363Diclofenac 25mg/Paracetamol 500 mg and Diclofenac 50 mg/Paracetamol 500 mg for Patients With Pain
NCT00101816Dasatinib (BMS-354825) in Subjects With Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate
NCT02872116Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer
NCT03943147An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis
NCT00277199Comparability DE vs CD-CHO1
NCT01492426Study Comparing Daclatasvir (BMS-790052) With Telaprevir Combined With Peginterferon Alfa-2a and Ribavirin in Patients With Chronic Hepatitis C Virus Infection
NCT00061815Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer
NCT00722358A Multiple Ascending Dose Study of BMS-650032 in HCV Infected Subjects
NCT04495010Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Nivolumab or Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Observation Compared With Adjuvant Nivolumab in Treatment-Naive High-risk Melanoma Participants
NCT06288191Neoadjuvant Nivolumab and Relatlimab in Cutaneous Squamous Cell Carcinoma
NCT03259425Neoadjuvant Trial of Nivolumab in Combination With HF10 Oncolytic Viral Therapy in Resectable Stage IIIB, IIIC, IVM1a Melanoma
NCT04021108Phase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers (BMS Protocol CA209-76L)
NCT00122382Remission and Joint Damage Progression in Early Rheumatoid Arthritis
NCT00826449Dasatinib and Erlotinib in Non-Small Cell Lung Cancer (NSCLC)
NCT00035152Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung Cancer
NCT00767325A Rheumatoid Arthritis Study to Assess Early Response to Abatacept+MTX as Defined by Improvement of Synovitis Measures by Power Doppler Ultrasonography
NCT00903006Trial of Fulvestrant, MK-0646, and Dasatinib for Metastatic Hormone Receptor-Positive HER2-Negative Breast Cancer
NCT00149591The Viability-Guided Angioplasty After Acute Myocardial Infarction-Trial (The VIAMI-Trial)
NCT05579574A Study to Investigate the Interaction of BMS-986322 and a Combined Oral Hormonal Contraceptive (Ethinyl Estradiol [EE]/Norethindrone [NET]) in Healthy Female Participants
NCT00455013A Phase II Study of Belatacept (BMS-224818) With a Steroid-free Regimen in Subjects Undergoing Kidney Transplantation
NCT04256213COL Immunotherapy Before Radiochimio + Ipilimumab
NCT05472623Neoadjuvant KRAS G12C Directed Therapy With Adagrasib (MRTX849) With or Without Nivolumab
NCT06549608A Retrospective Cohort Study of Mavacamten Patient Support Program in Canada
NCT00228423Trial of Clopidogrel After Surgery for Coronary Artery Disease (CASCADE Trial)
NCT00289627A Single Arm Study of Ipilimumab Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma
NCT00349518Study of Dasatinib in Imatinib Resistant or Intolerant Subjects With Chronic or Advanced Phase CML or Philadelphia Chromosome Positive ALL
NCT02450682Apixaban in Patients Who Undergo CIED Procedure- Randomized Pilot Study
NCT01244750Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
NCT06730750A Study of BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors
NCT00296218ARCHIPELAGO: Irbesartan in Patients With Acute Coronary Syndrome Without ST Segment Elevation
NCT00656890A Study of MDX-1100 in Subjects With Active Ulcerative Colitis
NCT03404635Monotherapy Anticoagulation To Expedite Home Treatment of Venous Thromboembolism
NCT03335540An Adaptive Study to Match Patients With Solid Tumors to Various Immunotherapy Combinations Based Upon a Broad Biomarker Assessment
NCT02387996A Study of Nivolumab in Participants With Metastatic or Unresectable Bladder Cancer
NCT02526017Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers
NCT00359450Study of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic NSCLC (Non Small Cell Lung Cancer)
NCT01762462Open Label Pharmacokinetic Study of SAR302503 in Subjects With Hepatic Impairment
NCT01218477Dasatinib Combination Therapy With the Smoothened (SMO) Inhibitor BMS-833923 in Chronic Myeloid Leukemia (CML)
NCT05426239Treatment Patterns and Outcomes in Participants With Advanced Melanoma in Germany Using a German Database
NCT06639607PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma
NCT00662545Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection
NCT00313300Safety Study of Apixaban in Recent Acute Coronary Syndrome
NCT00928031Long-term Data Collection for Subjects in MDX-010 Studies
NCT03219775Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Transitional Cell Carcinoma
NCT04570839COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors.
NCT00249795Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE I)